Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke Based on the Neurovascular Unit

NCT07003386 is registered in ClinicalTrials.gov with Shanghai Yueyang Integrated Medicine Hospital as lead sponsor.

NCT NCT07003386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07003386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke Based on the Neurovascular Unit
Lead sponsor
Shanghai Yueyang Integrated Medicine Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
September 15, 2025
Completion date
September 30, 2028
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke ais